Fibroblast Growth Factor -23 and Left Ventricular Hypertrophy in Hemodialysis Patients
Hany Elsaid Mansour;
Abstract
ardiovascular disease is the leading cause of morbidity and mortality in patient with ESRD, accounting for more than 50% of all deaths. In the past years, mineral metabolism abnormalities have been implicated in the risk of cardiovascular disease (CVD)
Other data
| Title | Fibroblast Growth Factor -23 and Left Ventricular Hypertrophy in Hemodialysis Patients | Other Titles | عامل نمو الخلايا الليفية 23 وتضخم البطين الأيسر لدى مرضى الغسيل الكلوى الدموى | Authors | Hany Elsaid Mansour | Keywords | Fibroblast Growth Factor -23 and Left Ventricular Hypertrophy in Hemodialysis Patients | Issue Date | 2011 | Description | ardiovascular disease is the leading cause of morbidity and mortality in patient with ESRD, accounting for more than 50% of all deaths. In the past years, mineral metabolism abnormalities have been implicated in the risk of cardiovascular disease (CVD) |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 106097Final Thesis Dr. Hany Mansour2.pdf | 434.1 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.